These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2847743)

  • 1. Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccine.
    Almond JW; Westrop GD; Wareham KA; Skinner MA; Evans DM; Magrath D; Schild GC; Minor PD
    Biochem Soc Symp; 1987; 53():85-90. PubMed ID: 2847743
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD; Macadam AJ; Stone DM; Almond JW
    Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
    Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
    Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.
    Dedepsidis E; Pliaka V; Kyriakopoulou Z; Brakoulias C; Levidiotou-Stefanou S; Pratti A; Mamuris Z; Markoulatos P
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):343-51. PubMed ID: 18328076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F; Da-Silva EF; Schatzmayr HG
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.
    Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM
    Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine.
    Martinez CV; Old MO; Kwock DK; Khan SS; Garcia JJ; Chan CS; Webster R; Falkovitz-Halpern MS; Maldonado YA
    J Infect Dis; 2004 Jul; 190(2):409-16. PubMed ID: 15216480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees.
    Karakasiliotis I; Markoulatos P; Katsorchis T
    Mol Cell Probes; 2004 Apr; 18(2):103-9. PubMed ID: 15051119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
    Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
    Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
    Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
    Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succession of mutations in the Sabin strain of type 3 poliovirus replicating in the central nervous system of monkeys.
    Lu Z; Asher DM; Levenbook IS; Chumakov KM
    Virology; 1996 Jun; 220(2):285-9. PubMed ID: 8661379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant polioviruses as candidate strains of oral poliovaccines.
    Nomoto A
    Dev Biol Stand; 1995; 84():123-7. PubMed ID: 7796944
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans.
    Friedrich F
    Acta Virol; 1998 Jun; 42(3):187-94. PubMed ID: 9842449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.